The market for chromatography resin in drug discovery is projected to grow from USD 290.7 Million in 2017 to USD 401.1 Million by 2022, at a CAGR of 6.65% from 2017 to 2022. Factors such as the growing demand for therapeutic antibodies and rising R&D in biopharmaceuticals are driving the market.

Browse 101 market data tables and 37 figures spread through 147 pages and in-depth TOC on "Chromatography Resin Market in Drug Discovery by Type (Natural, Synthetic, Inorganic Media), Technique (Ion Exchange, Affinity, Hydrophobic Interaction, Size Exclusion, Multi-Modal), and Region - Global Forecast to 2022"

Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=29294329

Natural polymer segment accounted for the largest share of the chromatography resin market in drug discovery.

Natural polymer was the largest segment of the chromatography resin market in drug discovery, in terms of value, in 2016. Agarose, cellulose, and dextran are the natural polymers that are most commonly used as resins in chromatography applications. The major advantage of these natural polymers is their hydrophilic nature, as they have a large number of hydroxyl groups in their structure. These provide functional sites for the coupling of suitable ligands.

North America is the largest market for chromatography resin in drug discovery.
On the basis of region, the chromatography resin market in drug discovery is segmented into North America, Europe, Asia-Pacific, and RoW. North America is the key market for chromatography resin in drug discovery. The U.S. is the leading market for chromatography resin in drug discovery in the region, followed by Canada. Strong growth in the monoclonal antibody therapeutics market of the region drives the demand for chromatography resin in drug discovery in this region.

Request Report Sample @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=29294329

Major players operating in the chromatography resin market in drug discovery are General Electric Company (U.S.), Merck KGaA (Germany), Pall Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Tosoh Corporation (Japan). These companies are adopting strategies such as new product launches, expansions, and contracts & agreements to strengthen their market position, widen their product portfolio, and increase their customer base.

The key constraint for the growth of the chromatography resin market in drug discovery is the lack of adequately skilled professionals. The pharmaceutical industry is currently witnessing a shortage of skilled professionals to operate chromatography instruments and perform techniques according to the industry requirements. The chromatography market has witnessed rapid technological advancements in the recent years. Therefore, proper usage of modern chromatography equipment requires expertise, relevant experience, and knowledge of different chromatography techniques.

Read More Insights At https://www.marketsandmarkets.com/Market-Reports/chromatography-resins-market-in-drug-discovery-29294329.html

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact MarketsandMarkets™:
Mr. Ashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441